McLemore launched Patient Capital in 2020 after a 20-year stint at Legg Mason working with Miller, who shot to fame after running the firm's Value Trust fund that outperformed the market for 15 years straight. Baltimore-based Patient Capital now oversees about $1.5 billion in assets. McLemore said she is a classic long-term investor who studies companies' intrinsic value, but she also has a knack for finding underappreciated opportunities based on consumer behavior.
However, McLemore believes that Delta differentiates itself from the rest by being a premium brand and it generates revenue from stable sources like loyalty programs. The stock is looking particularly attractive now after the Covid pandemic shock took down valuations drastically. DAL 5Y mountain Delta "I think now you're getting another chance here," McLemore said. "It's generating a lot of free cash flow which we expect that even in a recession ...